J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson consumer products executive Colleen Goggins' pending retirement could signal a larger executive-level overhaul at the firm
You may also be interested in...
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.
Elections Reshape FDA Oversight Scene On Capitol Hill
The Republican takeover in the House shuffles the leadership in committees crucial to the dietary supplement and OTC drug industries while likely setting the stage for cuts to FDA funding.
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.